Past Meeting| Keystone Symposia

Web Desc
New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet? joint with Advances in Neurodegenerative Disease Research and Therapy Organizer(s): Marco Prinz, Jonathan Kipnis and Irene Knuesel Date: June 17 - 21, 2018 Location: Keystone Resort, Keystone, CO, USA Sponsored by Biogen, BioLegend, Inc., Genentech, Inc., Merck & Co., Inc., Nestlé Institute of Health Sciences, Roche and Takeda Pharmaceutical Company Limited Summary of Meeting: As the Greek name implies, glia are commonly known as the glue of the nervous system but, as non-neuronal cells, they essentially shape many key functions of the central nervous system (CNS). In contrast to other glial cells, microglia are more closely related to the peripheral immune system than to the neuroectoderm, making them unique within the CNS. Recent data suggest that brain-resident microglia are functionally distinct from the bone marrow-derived macrophages that invade the CNS under pathological conditions. During the last few years, the advent of novel tools in imaging, genetics and immunology, in particular high-throughput sequencing methods, has dramatically improved research of microglial biology. Recent studies, making use of these new methodologies, have yielded unexpected results that challenge the traditional view of microglia as simply scavengers of the diseased CNS. This conference will highlight the latest developments in the function of microglia for the CNS during health and disease. Scholarship Deadline: February 15 2018 Discounted Abstract Deadline: February 15 2018 Abstract Deadline: March 15 2018 Discounted Registration Deadline: April 18 2018 Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support from these exhibitors at this conference: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge the generous grant for this conference provided by: National Institute of Neurological Disorders and Stroke (NINDS) Grant No. 1R13NS106976-01 Funding for this conference was made possible (in part) by 1R13NS106976-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet?

joint with Advances in Neurodegenerative Disease Research and Therapy

Organizer(s): Marco Prinz, Jonathan Kipnis and Irene Knuesel

Date: June 17 - 21, 2018
Location: Keystone Resort, Keystone, CO, USA

Sponsored by Biogen, BioLegend, Inc., Genentech, Inc., Merck & Co., Inc., Nestlé Institute of Health Sciences, Roche and Takeda Pharmaceutical Company Limited

Summary of Meeting:

As the Greek name implies, glia are commonly known as the glue of the nervous system but, as non-neuronal cells, they essentially shape many key functions of the central nervous system (CNS). In contrast to other glial cells, microglia are more closely related to the peripheral immune system than to the neuroectoderm, making them unique within the CNS. Recent data suggest that brain-resident microglia are functionally distinct from the bone marrow-derived macrophages that invade the CNS under pathological conditions. During the last few years, the advent of novel tools in imaging, genetics and immunology, in particular high-throughput sequencing methods, has dramatically improved research of microglial biology. Recent studies, making use of these new methodologies, have yielded unexpected results that challenge the traditional view of microglia as simply scavengers of the diseased CNS. This conference will highlight the latest developments in the function of microglia for the CNS during health and disease.

Scholarship Deadline: February 15 2018

Discounted Abstract Deadline: February 15 2018

Abstract Deadline: March 15 2018

Discounted Registration Deadline: April 18 2018

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support from these exhibitors at this conference:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS106976-01
Funding for this conference was made possible (in part) by 1R13NS106976-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found